Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Short-Term Debt issuances (2020 - 2022)

Roivant Sciences (ROIV) has disclosed Short-Term Debt issuances for 3 consecutive years, with $159.9 million as the latest value for Q4 2022.

  • For the quarter ending Q4 2022, Short-Term Debt issuances rose 339.28% year-over-year to $159.9 million, compared with a TTM value of $159.9 million through Dec 2023, down 55.11%, and an annual FY2023 reading of $159.9 million, up 339.28% over the prior year.
  • Short-Term Debt issuances was $159.9 million for Q4 2022 at Roivant Sciences, roughly flat from $159.9 million in the prior quarter.
  • Across five years, Short-Term Debt issuances topped out at $159.9 million in Q2 2022 and bottomed at -$36.4 million in Q4 2020.
  • Average Short-Term Debt issuances over 3 years is $71.2 million, with a median of $36.4 million recorded in 2021.
  • The sharpest move saw Short-Term Debt issuances soared 200.0% in 2021, then skyrocketed 339.28% in 2022.
  • Year by year, Short-Term Debt issuances stood at -$36.4 million in 2020, then skyrocketed by 200.0% to $36.4 million in 2021, then skyrocketed by 339.28% to $159.9 million in 2022.
  • Business Quant data shows Short-Term Debt issuances for ROIV at $159.9 million in Q4 2022, $159.9 million in Q2 2022, and $36.4 million in Q4 2021.